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19. The COVID-19 resource centre is hosted on Elsevier Connect, the 
company's public news and information website. 
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research content - immediately available in PubMed Central and other 
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As the prevalence of COVID-19 infection continues to rise, there is increased risk of disease 
transmission to healthcare workers performing procedures where the virus may aerosolize, such 
as computed tomography (CT) guided transthoracic lung biopsy. We report a case of an 
asymptomatic patient who was diagnosed with COVID-19 infection based on imaging findings 
at the time of CT guided transthoracic lung biopsy. IRB approval was not required for this case 
report. 
A 61 year-old asymptomatic male with prior tonsillar cancer was referred for computed 
tomography (CT) guided transthoracic lung biopsy of a suspicious nodule identified on chest CT 
one month prior (Figure 1). Pre-biopsy laboratory testing demonstrated a mildly decreased white 
blood cell count of 3.1k/mm2 (normal 4-11), with otherwise normal laboratory values.  
Pre-procedural CT in the prone position re-demonstrated the suspicious left lower lobe nodule, as 
well as multiple new ground-glass and nodular opacities in the periphery of both lungs (Figure 
2). The imaging findings raised concern for possible asymptomatic COVID-19 infection, and the 
lung biopsy was postponed. The patient was subsequently referred for polymerase chain reaction 
(PCR) testing, which confirmed COVID-19 infection. 
Up to 50% of patients infected with COVID-19 are either asymptomatic or capable of pre-
symptomatic disease transmission (1). A recent study of PCR proven COVID-19 patients found 
that 54% of the asymptomatic cohort had lung opacities present on CT (2). The most commonly 
reported chest CT findings of COVID-19 infection include peripheral predominant ground glass 
opacities and consolidations, sometimes with a rounded morphology (3).  
Although COVID-19 infection is transmitted primary through direct contact or respiratory 
droplets, patients with a cough can aerosolize the virus. Because many of the complications from 
CT-guided transthoracic lung biopsy are likely to induce coughing (4), there is increased risk of 
disease transmission to healthcare workers who may be using only standard universal 
precautions during the procedure. 
With widespread community transmission of COVID-19 in many parts of the United States, 
interventional radiologists performing CT-guided transthoracic procedures should carefully 
review pre-procedural imaging for findings associated with COVID-19 infection, including in 
asymptomatic patients. Depending on the clinical setting, it may be prudent to either defer the 
interventional procedure and obtain COVID-19 testing or use more stringent airborne 
precautions to avoid accidental exposure to the COVID-19 virus.  
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Figure 1. 
Non-contrast chest CT one month prior to transthoracic lung biopsy demonstrating a suspicious 
1.1x1.5cm left lower lobe nodule. No other lung abnormalities were present. 
 
Figure 2. Pre-procedural CT in the prone position prior to CT guided transthoracic lung biopsy, 
from cranial to caudal (A-C). There are multiple new ground glass opacities in the lung 
periphery, some with a rounded morphology (blue arrows). Suspicious left lower lobe nodule 
persists (white arrow). 




